| NCT ID | NCT06880705 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Illinois Institute of Technology |
| Condition | Substance Abuse |
| Study Type | INTERVENTIONAL |
| Enrollment | 124 participants |
| Start Date | 2025-02-10 |
| Primary Completion | 2027-07-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 124 participants in total. It began in 2025-02-10 with a primary completion date of 2027-07-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study is testing a new mutual-help group called "the TLC program" for transgender adults who use substances or are recently in recovery. The TLC Program is based on Acceptance and Commitment Therapy or "ACT" which is a type of mental health counseling that focuses on using mindfulness skills to connect a person to their values and improve their mental health. The TLC Program was developed by transgender and gender diverse community members, mental health providers, and researchers.
Eligibility Criteria
Inclusion Criteria: Eligible transgender adults must: 1. be 18 years of age or older; 2. speak primarily English; 3. live in the U.S.; 4. have a gender identity different from their assumed gender, or sex assigned, at birth; 5. identify as a person of transgender experience; 6. endorse having experienced two or more problem(s) related to alcohol or other drug use within the past 12 months.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06880705 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Substance Abuse. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06880705 currently recruiting?
Yes, NCT06880705 is actively recruiting participants. Contact the research team at aguy1@iit.edu for enrollment information.
Where is the NCT06880705 trial being conducted?
This trial is being conducted at Chicago, United States.
Who is sponsoring the NCT06880705 clinical trial?
NCT06880705 is sponsored by Illinois Institute of Technology. The trial plans to enroll 124 participants.